Kooth (KOO) Competitors

Renalytix (LON:RENX) and Kooth (LON:KOO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking.

Does the media refer more to RENX or KOO?

In the previous week, Renalytix's average media sentiment score of 0.00 equaled Kooth'saverage media sentiment score.

Company	Overall Sentiment
Renalytix	Neutral
Kooth	Neutral

Do insiders & institutionals have more ownership in RENX or KOO?

28.4% of Renalytix shares are owned by institutional investors. Comparatively, 65.0% of Kooth shares are owned by institutional investors. 35.7% of Renalytix shares are owned by insiders. Comparatively, 17.3% of Kooth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Is RENX or KOO more profitable?

Kooth has a net margin of 7.89% compared to Renalytix's net margin of -1,191.75%. Renalytix's return on equity of 293.20% beat Kooth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Renalytix	-1,191.75%	293.20%	-93.54%
Kooth	7.89%	18.59%	10.12%

Do analysts recommend RENX or KOO?

Kooth has a consensus target price of GBX 583.33, suggesting a potential upside of 312.98%. Given Kooth's stronger consensus rating and higher probable upside, analysts plainly believe Kooth is more favorable than Renalytix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Renalytix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community believe in RENX or KOO?

Renalytix received 11 more outperform votes than Kooth when rated by MarketBeat users. However, 92.31% of users gave Kooth an outperform vote while only 74.19% of users gave Renalytix an outperform vote.

Company	Underperform	Outperform
Renalytix	Outperform Votes 23 74.19%	Underperform Votes 8 25.81%
Kooth	Outperform Votes 12 92.31%	Underperform Votes 1 7.69%

Which has more volatility and risk, RENX or KOO?

Renalytix has a beta of 2.1, suggesting that its stock price is 110% more volatile than the S&P 500. Comparatively, Kooth has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.

Which has preferable earnings & valuation, RENX or KOO?

Kooth has higher revenue and earnings than Renalytix. Renalytix is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Renalytix	£9.22M	4.02	-£109.93M	-£21.19	-0.42
Kooth	£50.72M	1.02	£4.00M	£10.64	13.27

Summary

Kooth beats Renalytix on 11 of the 16 factors compared between the two stocks.